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ABSTRACT 
Objective: This case-control study aimed to determine whether the imbalance in 
Charcot-Marie-Tooth (CMT) disease is caused only by reduced proprioceptive input or 
whether the involvement of the vestibular nerve is an additional factor.  
Methods: 15 CMT patients (48±17y; 8 women) underwent cervical vestibular-evoked 
myogenic potentials, which reflect otolith-spinal reflex function, and quantitative 
horizontal search-coil head-impulse testing, which assesses the high-acceleration 
vestibulo-ocular reflex of the semicircular canals.  
Results: Relative to healthy age-matched control subjects, cervical vestibular-evoked 
myogenic potentials were found to be impaired in 75% (average p13 latency: 23.0 ± 2.7 
ms; p = 0.01; average n23 latency: 29.0 ± 1.8 ms; p = 0.01) and the quantitative head-
impulse test in 60% (average gain ± 1SD: 0.67 ± 0.24; p < 0.001) of patients. All 
patients with head-impulse test impairment also showed cervical vestibular-evoked 
myogenic potential abnormalities, while the reverse was not true.  
Conclusions: We conclude that the neuropathic process in CMT patients frequently 
involves the vestibular nerve and that cervical vestibular-evoked myogenic potentials 
may be more sensitive than quantitative head-impulse testing for detecting vestibular 
involvement, in particular at an early disease stage. 
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INTRODUCTION  
In patients with Charcot-Marie-Tooth disease (CMT) it is generally assumed that 
proprioceptive sensory loss causes sensory ataxia leading to postural instability. 
However, vestibular impairment could also contribute to the imbalance. In fact, 
involvement of the vestibular nerve in the polyneuropathic process has been shown to 
occur frequently in patients with non-inherited polyneuropathy 
1-4
 and interestingly, 
sensory neuropathy seems to be an integral part of the just recently characterized 
syndrome of cerebellar ataxia with bilateral vestibulopathy. 
5
 In inherited neuropathy, 
vestibular hypofunction has been, so far, documented only in single case reports, 
including the description of bilateral vestibular loss in two patients with Dejerine–Sottas 
syndrome 
6
 and of vestibular neuropathy in a Roma family with hereditary motor and 
sensory peripheral neuropathy due to mutations on chromosome 8p24. 
7
 Given the 
evidence that vestibular rehabilitation improves postural stability in patients with 
vestibulopathy, 
8
 identifying a concomitant vestibular impairment is clinically important.  
In the current study, we set out to determine the frequency of vestibular impairment 
in patients with CMT. By assessing vestibular semicircular canal and otolith function we 
further aimed to detect specific patterns of vestibular deficits.  
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MATERIAL AND METHODS 
Standard protocol approvals and patient consents. Informed consent was obtained 
from all participants after a full explanation of the experimental procedure. The protocol 
was approved by a local ethics committee and was in accordance with the ethical 
standards laid down in the 1964 Declaration of Helsinki for research involving human 
subjects.  
Study cohort and eligibility criteria. Participants of this case-control study were 
selected for eligibility from patients referred to our tertiary neurologic center for further 
evaluation of neuropathic symptoms between March 2009 to March 2010. Inclusion 
criteria were: clinically affected status defined as muscle weakness of at least the foot 
dorsiflexors. Exclusion criteria were other known disease or medication that may cause 
neuropathy, reluctance to undergo nerve conduction studies, low CMAP amplitude of 
the abductor pollicis brevis muscle (negative peak < 0.5 mV) hindering proper 
determination of the motor nerve conduction velocity (MNCV) of the median nerve.  
Procedure. Detailed history taking and complete neurologic examination were 
performed. Patients were specifically assessed for spontaneous and gaze-evoked 
nystagmus, correcting saccades following Halmagyi-Curthoys head impulses, 
9
 
positional and positioning nystagmus, muscle atrophy, weakness, weak or absent tendon 
reflex, as well as stand, gait, and limb ataxia. Sensory examinations included touch, 
pain, temperature, vibration, and position sense. Vibration sense was tested with a 128 
Hz tuning fork at the ankles, knees, and index fingers and considered reduced at 4/8 or 
below. 
10
 All patients were examined by one of four authors (A. Po., A. Pa., H. H. J., J. 
A. P.). Data about the genotype were collected in all but one patient (Patient ID 15), in 
whom family history was positive for Charcot-Marie-Tooth Type 1A.  
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All patients underwent electrophysiological investigations. Investigations were 
performed by one of two authors (A. A. T, J. A. P.) and supervised by two senior 
authors (K. P. W, H. H. J.). Standard nerve conduction studies (motor and sensory) 
included the median, ulnar, and peroneal nerves on one side (if the severity of the 
neurological impairments was asymmetric, the investigation was performed on the more 
affected side). Age-related normative values were taken from Ludin. 
11
 Charcot-Marie-
Tooth (CMT) neuropathies were subdivided in 1) a predominant demyelinating form 
characterized by nerve-conduction velocities < 38 m/s in upper-limb motor nerves and 
2) a primary axonal form with nerve-conduction velocities > 38 m/s in upper-limb motor 
nerves (subdivision according to 
12-14
).  
Vestibular function was characterized by cervical vestibular-evoked myogenic 
potentials (cVEMP) for otolith function assessment and the quantitative head impulse 
test (qHIT) for semicircular canal function assessment. cVEMP were registered from 
contracted sternocleidomastoid muscles (SCM). Air-conducted sound stimuli for 
cVEMP (500-Hz, 6 ms-tone bursts at 90-100 dB normal hearing level [nHL], total of 
200 bursts) were presented through calibrated headphones (Telephonics TDH39P) 
monaurally to the right and left ears. During stimulation, subjects were asked to sit and 
turn their head as much as possible to the side to tense their SCM. Electromyographic 
(EMG) activity was recorded (Viking V system, Nicolet Biomedical USA) from the 
upper half of the SCM muscle with a reference electrode on the upper sternum. The 
background SCM contraction was monitored online and measured over the 20 ms pre-
stimulus interval (using root mean square EMG). Signals of 200 air-conducted cVEMP 
stimuli were averaged. The resultant response consisted of an initial positive peak (p13) 
and a subsequent negative peak (n23). p13-n23 amplitudes, p13-, and n23-latencies were 
calculated for each ear. Because of the large inter-individual variability in cVEMP 
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amplitudes (ranging from 2 to 181 μV), side to side differences in uncorrected reflex 
amplitudes were expressed as asymmetry ratio (AR) calculated as 
15
:  
 
where 
 
is the larger and 
 
is the smaller amplitude obtained from stimulating 
each ear. 
16
 Subjects with bilaterally absent responses were not included in the 
calculation of asymmetry ratio. The upper normal limit of asymmetry ratio was set to 46 
% (value for uncorrected background EMG) as suggested by Wegampola and Colebatch. 
16
 18 age-matched healthy subjects (45 ± 15 y, range 25 - 67 y) served as controls. The 
average asymmetry ratio value in our healthy control group (26 ± 15 %; range 5 – 60 %) 
was comparable to Wegampola and Colebatch (23 %). 
16
 p13- and n23-latency values 
were 15.5 ± 1.9 ms and 25.5 ± 1.3 ms (average ± 1 standard deviation), respectively. 
Average ± 2 standard deviations were defined as the upper limit of the normal range, 
that is p13 = 19.3 ms and n23 = 28.1 ms.  
For qHIT, eye and head movements were recorded in a magnetic frame (Remmel 
type system, modified by A. Lasker, Baltimore, MA) using search-coils, which were 
calibrated before each session. 
17
 Horizontal head impulses (amplitude: 20-30°; duration: 
150–200 ms; peak velocity: about 300 °/s; peak acceleration: about 10,000 °/s2) were 
applied by an investigator standing behind the subject who was visually fixing upon a 
target light 1.24 m straight ahead. The directions of the head impulses were 
pseudorandomly intermingled and four to six impulses were performed in each 
direction. The gain of the horizontal semicircular-ocular reflex was determined by 
computing the coefficient eye-in-head displacement divided by head-in-space 
displacement as head-in-space moved from 3° to 7° eccentricity from straight ahead. 
18
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As the representative gain during head impulses to either side, the median value was 
computed. Median gain values were considered pathologic, if they were below two 
standard deviations of the average gain determined in healthy controls. This healthy 
control group consisted of 12 healthy subjects (six women; 43 ± 10 y), selected by age 
frequency matching from a previously published population of 28 healthy subjects (15 
women; 18 – 75 y, 44 ± 15 y). 19 
All patients were investigated by routine pure tone audiometry to ascertain the 
absence of conductive hearing loss. Hearing was normal in nine patients, while 
sensorineural hearing loss comprising the mid (> 0.5 kHz ≤ 2 kHz) to high (> 2 kHz ≤ 8 
kHz) frequency range was present in the remaining six patients (frequency range 
definition according to Stephens (2001) 
20
). The sensorineural hearing loss affected both 
ears symmetrically in five patients and was accentuated on the right ear in one patient.  
Statistical analysis. Statistical analysis was performed using MATLAB (The 
Mathworks, Natick, MA), version 7.5. Unpaired two-tailed t-test was used for average 
analysis and the Wilcoxon rank-sum test was used for CMT sub-classification analyses. 
Principal component analysis (PCA) was used for correlation analyses between 
vestibular and peripheral nerve conduction parameters, as PCA is more appropriate than 
standard linear regression analysis for dependent, i.e. inter-correlated variables. 
21
 For 
correlation analyses with age (independent variable) and vestibular and nerve 
conduction data, respectively, robust linear regression analysis (robustfit.m) was used. A 
level of significance of 0.05 was adopted and 95% confidence intervals (CI) calculated.  
 Poretti et al. - 8 - 
RESULTS 
At the time of the study the median age of patients (N = 15; eight women) was 48 (± 
17) years (range 23-74 y). Abnormal clinical findings included: 1) unilateral (N = 5) or 
bilateral (N = 2) abnormal bedside head-impulse test; 2) stand and gait ataxia (N = 11); 
3) sensory deficits (touch: N = 6; pain: N = 3; temperature: N = 3; position: N = 6; 
vibration: N = 8), muscle atrophy (N = 12), muscle weakness (N = 13), weak or absent 
tendon reflexes (N = 13), and pes cavus (N = 5).  
Charcot-Marie-Tooth (CMT) phenotypes included: CMT1, CMTX, CMT2, CMT4, 
and intermediate (DI) CMT (details summarized in Table 1). Five patients could not be 
classified.  The genotype included duplication in the peripheral myelin protein 22 gene 
(PMP22), mutation in the gap junction B1 gene (GJB1, Connexin 32), and point 
mutation in the myelin protein zero gene (MPZ). Six patients (one patient with CMT2, 
one patient with CMT4, 4 patients with unclassified CMT) remained genetically 
undefined, whereby mutations in the PMP22, GJB1, MPZ, and mitofusin 2 genes were 
excluded. Family history was positive in all six patients. Genetic testing was not 
performed in one patient (patient ID 15 in Table 1), but family history was positive for 
Charcot-Marie-Tooth Type 1A.  
On the basis of nerve-conduction studies and the genotype patients were classified 
into a primary demyelinating (N = 13) or a primary axonal group (N = 2, patient ID 5 
and ID 10 in Table 1). Average age between demyelinating (47 ± 13 y) and axonal (46 ± 
15 y) patients were not different (unpaired two-tailed t-test: p > 0.8). 
Cervical vestibular-evoked myogenic potentials (cVEMP) were registered in 14 
patients. Due to a technical defect, one patient was not tested by cVEMP. In 11 patients, 
cVEMP were detectable from both sternocleidomastoid muscles (SCM), in one patient 
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(patient ID 9) from one SCM side only, and in two patients (patient ID 6 and ID 4) 
cVEMP were bilaterally absent. For further comparison, the 74 year old patient (ID 4) 
with bilaterally absent responses was excluded since cVEMP can be absent also in 
healthy subjects over age 60 
22
. The remaining 13 patients included in further analysis 
were all aged < 60 years (see Fig. 2B).  
Figure 1 shows examples of cVEMP traces (averaged over 200 repetitions) recorded 
from the left (A) and right (B) SCM in one healthy subject (black line) and one patient 
(dashed grey line). In the patient (patient ID 13), uncorrected averaged raw peak-to-peak 
amplitudes were within the normal range of healthy subjects while p13- and n23-
latencies were prolonged in responses to clicks delivered on the left ear (dashed vertical 
lines depict upper limit of normal p13 and n23 latencies; for values see Methods).  
Averaged uncorrected raw peak-to-peak amplitudes (± 1 SD) in all patients (i.e. 26 
ears) were 91 ± 101 μV (Fig. 2A). Average asymmetry ratio (± 1 SD) of uncorrected 
amplitudes was 35 ± 26 % (Fig. 2B). Although average asymmetry ratio resulted within 
the normal range (37 ± 26 %; unpaired two-tailed t-test p > 0.2; cutoff of upper normal 
limit set to 46 % according to Wegampola and Colebatch 
16
), six of 13 patients showed 
abnormal values. Values ranged between 47 to 100 % (63 ± 17 %; unpaired two-tailed t-
test p < 0.001) in five patients and were bilaterally absent in patient ID 6 (see * in Fig 
2B). cVEMP latencies were abnormal in nine patients. p13 latencies (Fig. 2C) were 
prolonged in five patients (unpaired two-tailed t-test p = 0.01), in one patient on both 
sides (23.1 ± 0.6 ms), in one patient on the right side (21.7 ms), and in three patients on 
the left side only (21.8 ± 0.4 ms). n23 latencies (Fig. 2D) were prolonged in nine 
patients (unpaired two-tailed t-test p = 0.01): in six patients unilaterally (28.9 ± 0.7 ms; 
three right-sided and three left-sided) and in three patients bilaterally (29.8 ± 1.2 ms). 
Only in one patient (patient ID 11), both, p13 (23.1 ± 0.5 ms) and n23 (30.4 ± 1.3 ms) 
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latencies were prolonged in both ears. CMT sub-group analyses showed no differences 
for cVEMP asymmetry ratios, p13, and n23 latencies (Kruskal-Wallis: p > 0.2). Neither 
were differences found between predominant demyelinating (N = 10; asymmetry ratio: 
35 ± 30 %; p13: 19 ± 2 ms; n23: 27 ± 2 ms) and predominant axonal neuropathies (N = 
2; asymmetry ratio: 50 ± 5 %; p13: 18 ± 0.6 ms; n23: 27 ± 0.9 ms; unpaired two-tailed t-
test: p > 0.1). We emphasize, however, that sub-group analyses must be evaluated with 
caution because of the small number of patients participating in this study.  
Compared to healthy subjects, the average gain of the high-acceleration horizontal 
vestibulo-ocular reflex, as determined by the quantitative head impulse test (qHIT), was 
reduced in patients with CMT (Fig. 3; average gain ± 1 SD of pooled ears from healthy 
subjects: 0.86 ± 0.07; pooled ears from patients: 0.67 ± 0.24; paired t-test p < 0.001; 
symbols as in Fig. 2). Overall, nine of 15 patients showed deficient gain values in one 
(CMT1A, N = 1; CMTX, N = 1; undefined CMT, N = 2) or both directions (CMT1A, N 
= 1; CMT2, N = 1; DI-CMT, N = 1; undefined CMT, N = 2), while gain values to both 
sides were normal in six patients. As for cVEMP, average gain values during qHIT to 
either side were not different among CMT sub-groups (Kruskal-Wallis: p > 0.1) and 
between primary demyelinating (0.67 ± 0.2) and primary axonal neuropathies (0.67 ± 
0.04; unpaired two-tailed t-test: p > 0.1). Again, we emphasize that due to the small 
number of patients in the respective subgroups, this finding can only be preliminary.  
In summary, we found that vestibular function was impaired in the majority, i.e. in 14 
of 15, of our patients with CMT disease. In 8 of 13 patients (for comparison of otolith 
and semicircular canal function only patients with both, elicitable cVEMP and qHIT, 
were taken) both, otolith and semicircular canal function were impaired and the side of 
otolith and semicircular canal impairment (i.e. the affected ear) correlated in 6 patients. 
Interestingly, ‘isolated’ otolith impairment, as determined by increased asymmetry ratio 
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and / or prolonged p13-n23 cVEMP latencies, occurred more frequently (4/13 patients) 
than ‘isolated’ semicircular canal deficiency (1 /13 patients), as assessed by qHIT. 
Moreover, all patients with semicircular canal impairment also evidenced otolith 
abnormalities, while the reverse was not true.  
Vestibular function was further compared with peripheral nerve conduction 
parameters (see Table 1). Regression analyses demonstrated moderate correlation 
between cVEMP p13 latencies and median nerve conduction velocities (principal 
component analysis; R2=0.17, slope=-4.0, 95% CI=-47.3 to -2.1), between cVEMP p13 
latencies and peroneal nerve distal motor latencies (principal component analysis; 
R2=0.28, slope=1.7, 95% CI=1.3 to 9.2), and between cVEMP amplitudes and ulnar 
nerve distal motor latencies (principal component analysis; R2=0.3, slope=0.02, 95% 
CI=0.02 to 0.05). All other correlation analyses between vestibular and peripheral 
neuropathy data as well as correlation analyses (regression analysis) between age and 
electrophysiological data resulted non-significant. Thus, although the first two findings 
point towards a positive link between the degree of vestibular impairment and peripheral 
neuropathy deficiency, results, in particular also considering the moderate significance 
and the inverse correlation between cVEMP amplitudes and ulnar nerve distal motor 
latencies, should be interpreted with caution due to the small patient sample size.  
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DISCUSSION 
This study demonstrates the high prevalence of coexisting vestibular and peripheral 
neuropathy in a group of patients affected by Charcot-Marie Tooth disease (CMT). 
Vestibular impairment was present in the majority of CMT patients, irrespective of their 
clinical phenotype and their genotype. Interestingly, cervical vestibular-evoked 
myogenic potentials (cVEMP) were more frequently impaired than the quantitative head 
impulse test (qHIT) suggesting that the former might have a higher sensitivity in 
detecting vestibular, specifically otolith, impairment than the latter.  
Our results are in line with previous findings in a more heterogeneous population of 
patients with polyneuropathy, where we recently identified that postural imbalance was 
a multisensory balance disorder due to a concomitant vestibular and proprioceptive 
impairment, rather than due to an isolated proprioceptive sensory loss. 
3
  
Characterizing patients with vertigo and / or dizziness requires information 
concerning the function of the vestibular end-organs as a whole. While it is known from 
single case reports that semicircular canal function can be involved in inherited 
neuropathies, 
6, 7
 to our best knowledge, this is the first study characterizing otolith 
function. cVEMP were investigated in this study, as vestibulo-spinal pathways are 
important structures when evaluating balance control.  
Air conducted sound stimuli used to induce cVEMP activate vestibular afferent 
neurons predominantly originating from the saccular macula that project via vestibulo-
spinal pathways to the neck muscles, specifically to the motor neurons of the ipsilateral 
sternocleidomastoid muscle. A lesion anywhere in these pathways can result in 
abnormal cVEMP. In our study we found that cVEMP latency was affected more often 
than cVEMP amplitude. This pattern is in analogy with other pathologies affecting 
 Poretti et al. - 13 - 
primary the vestibular nerve or central vestibular pathways, such as multiple sclerosis, 
vestibular schwannoma, and inferior vestibular neuritis, 
23, 24
 and explained by a 
reduction in conduction velocity along the nerve fibers. 
25
 In fact, the majority of our 
patients had demyelinating neuropathy, which results in slow nerve-conduction 
velocities. In contrast, other primary vestibular end-organ disorders, e.g. Menière’s 
disease, 
26
 predominantly evidence reduced cVEMP amplitudes while latencies are 
relatively preserved (see Wegampola et al. (2005) for review 
15
).  
When comparing results from cVEMP to qHIT, our study suggests that cVEMP may 
be more sensitive for detecting vestibular involvement in CMT patients. In fact, beside 
the higher proportion of cVEMP compared to qHIT abnormalities found in our patients, 
we also observed that reduced qHIT was always associated with cVEMP abnormalities 
while the reverse was not true. That patients’ average qHIT differed from healthy 
controls while it did not for cVEMP parameters, furthermore, indicates that cVEMP may 
be particularly useful for detecting early stages of vestibular impairment. Presumably, 
differences between cVEMP and qHIT sensitivity rise from prolonged latencies 
appearing earlier due to the polysynaptic pathway activation in cVEMP versus to the 
oligosynaptic pathways stimulated by qHIT. 
The small number of patients and the heterogeneous phenotype are of course 
limitations of this study and comparison of vestibular function among different CMT 
genotypes was not reliably possible. The high percentage of vestibular impairment found 
in our small cohort, nevertheless, emphasizes the importance of routinely investigating 
vestibular function in CMT patients, ideally by cVEMP. Fortunately, technical 
advancements within the last few years have made laboratory HIT 
27
 and cVEMP 
28
 
assessment easily accessible and have paved the way for exploring its clinical 
applicability, in particular with regards to patients symptoms, which, to date, still 
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remains a major unresolved issue.
29
 However, recognizing a combination of vestibular 
impairment and peripheral neuropathy is in fact highly relevant since physical therapy 
should then focus on vestibular exercises, which have been shown to enhance vestibular 
function and improve compensatory sensory strategies, in particular, vision. 
30
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FIGURES 
Figure 1. Examples of cVEMP responses 
Legend: Examples of cVEMP responses recorded from the left (left panel) and right 
(right panel) sternocleidomastoid muscles (SCM) in one healthy subject (black line) and 
in one patient (dashed grey line). Traces consist of averaged (200 repetitions) unrectified 
electromyogram signals from each SCM. Note the prolonged p13n23 peak latencies 
evoked by air-conducted sound stimuli delivered in the patients left ear via headphones 
(left panel). Peak-to-peak p13n23 amplitudes, in contrast, are similar for the patient and 
healthy subject. Dashed vertical lines: upper limit of normal p13 and n23 latencies.  
Figure 2. cVEMP uncorrected average amplitudes, asymmetry ratio, p13 and n23 
latencies of individual patients 
Legend: cVEMP uncorrected average amplitudes of individual patients (A), asymmetry 
ratio (B), p13 (C) and n23 (D) latencies of individual patients. (A) cVEMP amplitudes to 
air-conducted sound stimuli delivered to both ears in individual patients are connected 
by dashed lines. Circles on the left and right: ears with higher and lower amplitude 
responses, respectively. Filled square: mean ± 1SD of healthy controls. (B) Side to side 
differences of uncorrected cVEMP amplitudes expressed as asymmetry ratio plotted 
against patients’ age. Symbols depict CMT phenotypes: □: patients classified as 
CMT1A, ◊: as CMT2, +: as CMTX, x: as DI- CMT, *: as undefined CMT. : patients’ 
mean asymmetry ratio (± 1 SD) plotted against the subjects’ mean age . Note that in the 
single patient with CMT4D no cVEMPS could be elicited bilaterally, therefore this 
subgroup is not shown. Horizontal dashed line: upper normal limit for healthy subjects 
(average + 2 SD). (C, D) p13 and n23 latencies for pooled ears from individual patients. 
Symbols of subgroups as in subpanel B. : mean and 95% confidence interval of all 
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patients. Horizontal dashed lines: upper and lower latency limits (average ± 2 SD) of 
healthy subjects.  
Figure 3. Gains of the horizontal vestibulo-ocular reflex during head impulses to both 
sides in patients and healthy controls 
Legend: Gains of the horizontal vestibulo-ocular reflex during head impulses to both 
sides in patients and healthy controls. Mean and 95% confidence interval over all 
healthy subjects (filled square on the left), all patients (filled circle on the right) and of 
patients’ subgroups (symbols as in Figure 2) are depicted. Horizontal dashed line: lower 
gain limits of healthy subjects (average - 2 SD). 
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Table 1. Phenotype, genotype and electrophysiological results of patients with Charcot-
Marie-Tooth disease  
 
 Phenotype  Genotype  Median nerve Ulnar nerve Peroneal nerve 
 
Patient ID/     MNCV DL MNCV DL MNCV DL 
Age/     (45-52)* (<3.5-4)* (41-45)* (<3.1-3.5) * (37-44)* (<5-.9)* 
Sex/ 
1/47/F CMT1A PMP22 dupl.  34 14.3 32 7.8 27. 4.5 
2/61/M CMT1A PMP22 dupl.  n.p. n.p. 13 8.5 11 11.2 
3/56/F CMT1A PMP22 dupl.  26 9 32 7.4 28 10.3 
4/74/F CMT1A PMP22 dupl.  n.p. n.p. 16 11.3 12 16.4 
5/57/M CMT2 undefined  41 6.2 42 7.7 0 0 
6/50/F CMT4D undefined  27 11 31.5 8.6 n.p. n.p. 
7/35/F CMTX1 GJB1/Cx32  41 3.9 43.5 3 36 5.1 
8/49/M CMTX1 GJB1/Cx32  34 5.4 41 3.5 19 3.9 
9/23/M CMTX1 GJB1/Cx32  28 8.5 n.p. n.p. n.p. n.p. 
 10/43/F DI-CMT MPZ  30 5.6 43 3.4 31 5.7 
11/44/M CMT undefined  28 6.8 31 5.4 12 13.5 
12/53/M CMT undefined  34 7.3 41 5.2 25 7.9 
13/47/F CMT undefined  37 4.9 45 4.6 30 6.7 
14/25/M CMT undefined  41 5.2 38 5.4 33 4.1 
15/23/F CMT n.p.       16 8 n.p. n.p. 25 11
 
 
 
Legend: F = female; M = male; MNCV= motor nerve conduction velocity (m/s); DL= distal motor latency (ms); *: 
normal values of MNCV and DL; n.p. = not performed; CMT=Charcot–Marie–Tooth disease; CMT1=autosomal-
dominant demyelinating CMT; CMT2=autosomal-dominant or autosomal-recessive axonal CMT; DI-
CMT=intermediate CMT; CMT4=autosomal-recessive demyelinating CMT; CMTX=X-linked CMT; 
GJB1/Cx32=gap junction B1/connexin 32;  PMP22 dupl.=peripheral myelin protein 22 duplication; MPZ=myelin 
protein zero. Normal values reported in parenthesis. 
  
 Poretti et al. - 18 - 
REFERENCES 
 
1. Aranda C, Meza A, Rodriguez R, Mantilla MT, Jauregui-Renaud K. Diabetic 
polyneuropathy may increase the handicap related to vestibular disease. Arch Med Res 
2009;40:180-185. 
2. Frohman EM, Tusa R, Mark AS, Cornblath DR. Vestibular dysfunction in 
chronic inflammatory demyelinating polyneuropathy. Ann Neurol 1996;39:529-535. 
3. Palla A, Schmid-Priscoveanu A, Studer A, Hess K, Straumann D. Deficient high-
acceleration vestibular function in patients with polyneuropathy. Neurology 
2009;72:2009-2013. 
4. Straumann D, Schmid-Priscoveanu A, Studer A, Hess K, Palla A. Progressive 
vestibular impairment in patients with polyneuropathy. Ann N Y Acad Sci 
2009;1164:239-241. 
5. Szmulewicz DJ, Waterston JA, Halmagyi GM, et al. Sensory neuropathy as part 
of the cerebellar ataxia neuropathy vestibular areflexia syndrome. Neurology 
2011;76:1903-1910. 
6. Jen J, Baloh RH, Ishiyama A, Baloh RW. Dejerine-Sottas syndrome and 
vestibular loss due to a point mutation in the PMP22 gene. J Neurol Sci 2005;237:21-24. 
7. Butinar D, Zidar J, Leonardis L, et al. Hereditary auditory, vestibular, motor, and 
sensory neuropathy in a Slovenian Roma (Gypsy) kindred. Ann Neurol 1999;46:36-44. 
8. Hillier SL, McDonnell M. Vestibular rehabilitation for unilateral peripheral 
vestibular dysfunction. Cochrane Database Syst Rev:CD005397. 
9. Halmagyi GM, Curthoys IS. A clinical sign of canal paresis. Arch Neurol 
1988;45:737-739. 
10. Martina IS, van Koningsveld R, Schmitz PI, van der Meche FG, van Doorn PA. 
Measuring vibration threshold with a graduated tuning fork in normal aging and in 
 Poretti et al. - 19 - 
patients with polyneuropathy. European Inflammatory Neuropathy Cause and Treatment 
(INCAT) group. J Neurol Neurosurg Psychiatry 1998;65:743-747. 
11. Ludin HP, ed. Praktische Elektromyographie, 4 ed. Stuttgart: Ferdinand Enke, 
1993. 
12. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory 
neuropathy types I and II. Brain 1980;103:259-280. 
13. Lewis RA, Sumner AJ, Shy ME. Electrophysiological features of inherited 
demyelinating neuropathies: A reappraisal in the era of molecular diagnosis. Muscle 
Nerve 2000;23:1472-1487. 
14. Pareyson D. Guidelines for the diagnosis of Charcot-Marie-Tooth disease and 
related neuropathies. Ad hoc Working Group of the Peripheral Nervous System Study 
Group, Italian Neurological Society. Ital J Neurol Sci 1999;20:207-216. 
15. Welgampola MS, Colebatch JG. Characteristics and clinical applications of 
vestibular-evoked myogenic potentials. Neurology 2005;64:1682-1688. 
16. Welgampola MS, Colebatch JG. Vestibulocollic reflexes: normal values and the 
effect of age. Clin Neurophysiol 2001;112:1971-1979. 
17. Straumann D, Zee DS, Solomon D, Lasker AG, Roberts DC. Transient torsion 
during and after saccades. Vision Res 1995;35:3321-3334. 
18. Palla A, Straumann D. Recovery of the high-acceleration vestibulo-ocular reflex 
after vestibular neuritis. J Assoc Res Otolaryngol 2004;5:427-435. 
19. Palla A, Hegemann S, Widmer U, Straumann D. Vestibular and auditory deficits 
in Fabry disease and their response to enzyme replacement therapy. J Neurol 
2007;254:1433-1442. 
20. Stephens D, ed. Audiological terms 1ed: Whurr, 2001. 
 Poretti et al. - 20 - 
21. Bjasch D, Bockisch CJ, Straumann D, Tarnutzer AA. Differential effects of 
visual feedback on subjective visual vertical accuracy and precision. PLoS One 
2012;7:e49311. 
22. Colebatch JG, Halmagyi GM, Skuse NF. Myogenic potentials generated by a 
click-evoked vestibulocollic reflex. J Neurol Neurosurg Psychiatry 1994;57:190-197. 
23. Halmagyi GM, Aw ST, Karlberg M, Curthoys IS, Todd MJ. Inferior vestibular 
neuritis. Ann N Y Acad Sci 2002;956:306-313. 
24. Murofushi T, Halmagyi GM, Yavor RA, Colebatch JG. Absent vestibular evoked 
myogenic potentials in vestibular neurolabyrinthitis. An indicator of inferior vestibular 
nerve involvement? Arch Otolaryngol Head Neck Surg 1996;122:845-848. 
25. Bandini F, Beronio A, Ghiglione E, Solaro C, Parodi RC, Mazzella L. The 
diagnostic value of vestibular evoked myogenic potentials in multiple sclerosis. J Neurol 
2004;251:617-621. 
26. Murofushi T, Shimizu K, Takegoshi H, Cheng PW. Diagnostic value of 
prolonged latencies in the vestibular evoked myogenic potential. Arch Otolaryngol Head 
Neck Surg 2001;127:1069-1072. 
27. Weber KP, MacDougall HG, Halmagyi GM, Curthoys IS. Impulsive testing of 
semicircular-canal function using video-oculography. Ann N Y Acad Sci 
2009;1164:486-491. 
28. Rosengren SM, Welgampola MS, Colebatch JG. Vestibular evoked myogenic 
potentials: past, present and future. Clin Neurophysiol 2010;121:636-651. 
29. Palla A, Straumann D, Bronstein AM. Vestibular neuritis: vertigo and the high-
acceleration vestibulo-ocular reflex. J Neurol 2008;255:1479-1482. 
30. Herdmann SJ. Assessment and management of bilateral vestibular loss. In: Wolf 
SL, ed. Vestibular rehabilitation: F.A. Davis Company, 1994: 316-330. 
 


Healthy
controls
0
0.2
0.4
0.6
0.8
1
ho
riz
on
ta
l v
es
tib
ul
o−
oc
ul
ar
 re
fle
x 
ga
in
All
patients Subgroups
Figure 3
